EMA’s guide to help developers of gene therapy medicinal products (GTMPs) and cell-based medicinal products (CBMPs) navigate the most important regulatory requirements during the non-clinical development phase
View this resource Bookmark this resource
European Medicines Agency. EMA’S GUIDE ON ADVANCED THERAPY MEDICINAL PRODUCTS. Non-Clinical Development Flowchart. Version 1.0 – 29 November 2021
Published by EMA
Gene TherapyNon-Clinical Development SchemeMedical Products